Status:
TERMINATED
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
Lead Sponsor:
Bayer
Conditions:
Hypertension, Pulmonary
Ventricular Dysfunction, Left
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The aim of this study is to assess whether single oral doses of Riociguat safely improve the cardiovascular function in patients with pulmonary hypertension associated with left ventricular diastolic ...
Eligibility Criteria
Inclusion
- Male and female patients with symptomatic pulmonary hypertension due to left ventricular diastolic dysfunction
Exclusion
- Types of pulmonary hypertension other than group 2.2 of Dana Point Classification
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01172756
Start Date
July 1 2010
End Date
October 1 2012
Last Update
November 4 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Graz, Styria, Austria, 8020
2
Graz, Styria, Austria, 8036
3
Linz, Upper Austria, Austria, 4010
4
Vienna, Vienna, Austria, 1090